Related Experiment Video
Updated: Aug 17, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Assembly in vitro of tau protein and its implications in Alzheimer's disease
Jesús Avila1, Mar Pérez, José J Lucas
1Centro de Biología Molecular "Severo Ochoa", Facultad de Ciencias, Campus de Cantoblanco, Universidad Autónoma de Madrid, 28049 - Madrid, Spain. javila@cbm.uam.es
Abstract:
Tau is a microtubule associated protein that is also the main component of the aberrant filaments that form aberrant structures like the neuropil threads or the neurofibrillary tangles, found in the brain of Alzheimer's disease patients. The assembly of tau aberrant filaments could be reproduced in vitro by using a high concentration of tau protein or, at lower protein concentrations, by adding some compounds like polyanions, fatty acids (and derivates), and others. In this mini-review a descriptive analysis of the different conditions needed for in vitro tau polymerization are summarized.
Insights
This study reviews conditions for in vitro tau polymerization. Understanding tau protein assembly is key to Alzheimer's disease research.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Tau protein is a key component of neurofibrillary tangles in Alzheimer's disease.
- Aberrant tau filaments form structures like neuropil threads and neurofibrillary tangles.
Purpose of the Study:
- To summarize the conditions required for in vitro tau polymerization.
- To provide a descriptive analysis of tau assembly in a laboratory setting.
Main Methods:
- Literature review of studies on tau protein polymerization.
- Analysis of factors influencing in vitro tau assembly.
Main Results:
- In vitro tau polymerization can be induced by high tau protein concentrations.
- Lower tau concentrations require additives like polyanions and fatty acids for polymerization.
Conclusions:
- Reproducing tau polymerization in vitro is achievable under specific conditions.
- This research aids in understanding Alzheimer's disease pathology through tau assembly studies.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

